Drug Type Universal CAR-T |
Synonyms Allogeneic CAR-T targeting CD7 |
Target |
Action inhibitors |
Mechanism CD7 inhibitors(T-cell antigen CD7 inhibitors) |
Therapeutic Areas |
Active Indication- |
Originator Organization |
Active Organization- |
Inactive Organization |
Drug Highest PhasePendingPhase 1 |
First Approval Date- |
Regulation- |
Indication | Highest Phase | Country/Location | Organization | Date |
---|---|---|---|---|
Precursor T-Cell Lymphoblastic Leukemia-Lymphoma | Phase 1 | China | 22 Jan 2020 | |
T-cell Acute Lymphoblastic Leukemia/Lymphoma | Phase 1 | China | 22 Jan 2020 | |
T-Cell Lymphoma | Phase 1 | China | 22 Jan 2020 |